Metformin Versus Insulin in the Treatment of Gestational Diabetes Mellitus

The purpose of this study is to determine if metformin therapy prevents fetal macrosomy in gestational diabetes mellitus to the same extent as insulin therapy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gestational Diabetes Mellitus Diabetes Mellitus Diabetes, Gestational Endocrine System Diseases Female Urogenital Diseases and Pregnancy Complications Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases Pregnancy Complications Urogenital Diseases

Age range

18 year–50 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Oulu University Hospital

Oulu, 90029, Finland

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

gestational diabetes mellitus diagnosed between 12-34 pregnancy weeks if normoglycemia is not reached with diet

Exclusion criteria

hypertension with pharmacological treatment or preeclampsia
multiple pregnancy
liver or kidney disease

Treatment and study plan

metformin

Drug

Insulin

Drug

Primary outcomes

Percentage of fetal macrosomy

Sponsors and collaborators

Lead sponsor

University of Oulu

Other

Registry information

Official study title

Metformin Versus Insulin in the Treatment of Gestational Diabetes Mellitus: a Randomized Controlled Study

Important dates

Study start: 2005
Primary completion: 2009
Study completion: 2009
First posted: Mar 16, 2010
Registry last updated: Mar 16, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed